Literature DB >> 32288933

Eosinophilia-myalgia syndrome induced by excessive L-tryptophan intake from cashew nuts.

Marko Barešić1, Dubravka Bosnić1, Marija Bakula1, Kamelija Žarković1.   

Abstract

Eosinophilia is characterized by more than 0.5 × 109 eosinophils per liter in the full blood count. A wide range of conditions, from asthma to parasitic infections, autoimmune diseases, and certain forms of cancer, have been known to trigger abnormally high amount of eosinophils. It is essential to reach the correct diagnosis and treat the underlying disease aggresively. Definition of the eosinophilia-myalgia syndrome was offered in 1980s by Centers for Disease Control and Prevention for surveillance purposes, and criteria were revised in 2001, with high specificity. We report a case of 59-year old female who started a special weight-reducing diet regimen that included excessive cashew nut ingestion. Several months after she has presented with periferal blood eosinophilia and constitutional symptoms. Detailed work-up has not found elements for haematological, systemic autoimmune, neoplastic or infectious disease. She was diagnosed with eosinophilia-myalgia syndrome due to extreme L-tryptophan intake, a compound found in the cashew nut's oil. She responded well to cashew nut withdrawal and steroid therapy. In the follow-up period she remained stable with normal eosinophil count and there was not a need for any specific therapy. © Versita Warsaw and Springer-Verlag Berlin Heidelberg 2014.

Entities:  

Keywords:  Cashew nuts; Eosinophilia-myalgia syndrome; Hypereosinophilic syndrome; L-tryptophan

Year:  2014        PMID: 32288933      PMCID: PMC7102313          DOI: 10.2478/s11536-013-0339-2

Source DB:  PubMed          Journal:  Cent Eur J Med        ISSN: 1895-1058


  7 in total

1.  Rigorous new approach to constructing a gold standard for validating new diagnostic criteria, as exemplified by the eosinophilia-myalgia syndrome.

Authors:  P A Hertzman; D J Clauw; J Duffy; T A Medsger; A R Feinstein
Journal:  Arch Intern Med       Date:  2001-10-22

Review 2.  Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy.

Authors:  Jason Gotlib; N C P Cross; D Gary Gilliland
Journal:  Best Pract Res Clin Haematol       Date:  2006       Impact factor: 3.020

3.  Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan.

Authors:  Jeffrey A Allen; Alicia Peterson; Robert Sufit; Monique E Hinchcliff; J Matthew Mahoney; Tammara A Wood; Frederick W Miller; Michael L Whitfield; John Varga
Journal:  Arthritis Rheum       Date:  2011-11

4.  Is the L-tryptophan metabolite quinolinic acid responsible for eosinophilic fasciitis?

Authors:  R Noakes; L Spelman; R Williamson
Journal:  Clin Exp Med       Date:  2006-06       Impact factor: 3.984

5.  Review article toxic oil syndrome: review of immune aspects of the disease.

Authors:  Rachel Patterson; Dori Germolec
Journal:  J Immunotoxicol       Date:  2005-01-01       Impact factor: 3.000

6.  [Current differential diagnosis of hypereosinophilic syndrome].

Authors:  Vera Dinić-Uzurov; Vesna Lalosević; Ivana Milosević; Ivana Urosević; Dusan Lalosević; Stevan Popović
Journal:  Med Pregl       Date:  2007 Nov-Dec

7.  [Acute respiratory failure as a manifestation of eosinophilia-myalgia syndrome associated with L-tryptophan intake].

Authors:  Tiago de Araujo Guerra Grangeia; Marcelo Schweller; Ilma Aparecida Paschoal; Lair Zambon; Mônica Corso Pereira
Journal:  J Bras Pneumol       Date:  2007 Nov-Dec       Impact factor: 2.624

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.